Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)

HKSE - HKSE Delayed Price. Currency in HKD
0.880-0.010 (-1.12%)
At close: 03:44PM HKT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/29/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
487.42M543.44M582.66M560.25M661.10M627.48M
Enterprise Value
78.80M130.55M276.09M311.11M413.52M384.04M
Trailing P/E
2.962.883.173.243.844.21
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.540.630.660.690.820.82
Price/Book (mrq)
0.290.320.340.330.390.37
Enterprise Value/Revenue
0.100.601.501.611.782.23
Enterprise Value/EBITDA
0.434.095.297.807.026.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.09
52-Week Change 3-27.27%
S&P500 52-Week Change 3-12.31%
52 Week High 31.320
52 Week Low 30.840
50-Day Moving Average 30.920
200-Day Moving Average 31.033

Share Statistics

Avg Vol (3 month) 367.11k
Avg Vol (10 day) 386.4k
Shares Outstanding 5172.5M
Implied Shares Outstanding 6N/A
Float 8128.99M
% Held by Insiders 125.23%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 26, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sep 30, 2022

Profitability

Profit Margin 18.30%
Operating Margin (ttm)17.67%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)825.21M
Revenue Per Share (ttm)1.47
Quarterly Revenue Growth (yoy)25.40%
Gross Profit (ttm)580M
EBITDA 179.07M
Net Income Avi to Common (ttm)150.97M
Diluted EPS (ttm)0.300
Quarterly Earnings Growth (yoy)-42.90%

Balance Sheet

Total Cash (mrq)376.63M
Total Cash Per Share (mrq)0.67
Total Debt (mrq)1.81M
Total Debt/Equity (mrq)0.12
Current Ratio (mrq)N/A
Book Value Per Share (mrq)2.73

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement